| # | Drug | Count |
|---|---|---|
| 0 | ATORVASTATIN CALCIUM | 36 |
| 1 | ASPIRIN | 27 |
| 2 | ASPIRIN 325 MG | 26 |
| 3 | ASPIRIN 81 MG | 26 |
| 4 | INSULIN LISPRO | 18 |
| 5 | INSULIN HUMAN | 15 |
| 6 | OLANZAPINE | 13 |
| 7 | OLANZAPINE PAMOATE | 13 |
| 8 | CELECOXIB | 12 |
| 9 | SIMVASTATIN | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ERGOTAMINE TARTRATE AND CAFFEINE | 1 | 0.0037 |
| 1 | VECURONIUM BROMIDE | 1 | 0.0007 |
| 2 | NIZATIDINE | 1 | 0.0007 |
| 3 | ETOMIDATE INJECTION | 1 | 0.0005 |
| 4 | ETOMIDATE | 1 | 0.0004 |
| 5 | TELMISARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0004 |
| 6 | INSULIN HUMAN | 15 | 0.0004 |
| 7 | 1168 BURN SPRAY | 1 | 0.0003 |
| 8 | OLANZAPINE PAMOATE | 13 | 0.0003 |
| 9 | ALLANTOIN | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 39 |
| 1 | Platelet Aggregation Inhibitor [EPC] | 27 |
| 2 | Insulin Analog [EPC] | 25 |
| 3 | Insulin [EPC] | 15 |
| 4 | beta-Adrenergic Blocker [EPC] | 15 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 14 |
| 6 | Atypical Antipsychotic [EPC] | 13 |
| 7 | Loop Diuretic [EPC] | 12 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 10 |
| 9 | Angiotensin 2 Receptor Blocker [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Insulin [EPC] | 15 | 0.0003 |
| 1 | Vitamin D2 Analog [EPC] | 2 | 0.0003 |
| 2 | Blood Viscosity Reducer [EPC] | 1 | 0.0002 |
| 3 | Vitamin D Analog [EPC] | 2 | 0.0001 |
| 4 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 1 | 0.0001 |
| 5 | Sulfone [EPC] | 1 | 0.0001 |
| 6 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 2 | 0.0001 |
| 7 | Cardiac Glycoside [EPC] | 4 | 0.0001 |
| 8 | Insulin Analog [EPC] | 25 | 0.0001 |
| 9 | beta-Adrenergic Blocker [EPC] | 15 | 0.0000 |